Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Research Article Volume 3 Issue 8

Low Prevalence of Hepatitis B and Hepatitis C Infection in Gujarat and Maharashtra States of Western India

Sulabhsinh Solanki3*, Nikhil Patel1, Deepak Amarapurkar2, Anjali Amrapurkar2, Sanjay Patel1, Chetan Lakhani1, Payal Patel3, Ayusi Patel1, Parthvi Dani1, Jinal Ka Patel3, Lisma Patel3, Hetal Patel3, Ankita Thakkar1 and Nitiraj Shete4

1Jivandeep Hospital, Anand, Gujarat, India
2Bombay Hospital and Medical Research Centre, Mumbai, Maharashtra, India
3Shri A. N. Patel P. G. Institute, Anand, Gujarat, India
4Department of Statistics, Sardar Patel University, Vallabh Vidyanagar, Anand, Gujarat, India

*Corresponding Author: Sulabhsinh Ganpatsinh Solanki, Head and Associate Professor, Shri A. N. Patel P. G. Institute, Anand, Gujarat, India.

Received: June 02, 2020; Published: July 30, 2020

Reprints View PDF Related Articles

×

Abstract

 Prevalence of hepatitis B viral infection (HBV) in India is varying from 3 to 12%, which falls in to intermediate prevalence zone. Prevalence of hepatitis C viral infection (HCV) in India varies from 0.3 to 4% among blood donor population. Previous data from western India suggests HBV prevalence of 1.6 - 5.9% and HCV prevalence of 0.2 - 15.9%. Most of these data are almost 10 years old and based on selected population. Therefore, the main aim of the present study was to find out recent prevalence of HBV and HCV from multiple sources. Data on prevalence of HBV and HCV was collected prospectively from multiple sources that include general population, blood donor population, hospital attending population, and liver clinic population. HBV prevalence was as follows: general population data: 166/1758 (0.94%); blood donor data: 2039/172316 (1.18%) hospital attending population: 133/13177 (1%); liver clinic data: 2637/12251 (21.5%). HCV prevalence was as follows: general population: 1/2388 (0.040%); blood donor data: 666/171306 (0.38%); hospital attending population: 12/2597 (0.46%) liver clinic data: 916/12251 (7.4%). In Western India, there is very low prevalence of HBV and HCV; making it a low prevalence area.

Keywords: Hepatitis B; Hepatitis C; Chronic Liver Disease; Hepatocellular Carcinoma

×

References

  1. Bulle PA., et al. “Prevalence of Hepatitis B surface antigen (HBsAg) positivity among general population in Yavatmal (Maharashtra), India”. International Journal of Current Microbiology and Applied Sciences7 (2016): 513-517.
  2. Guan R. “Epidemiology of hepatitis B infection in East and Southeast Asian countries”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK, Okuda K. First Ed. Harcourt India Pvt. Ltd, (2002): 9-18.
  3. Chowdhury A. “Epidemiology of hepatitis B virus infection in India”. In: Hepatitis B Annual-2004, Ed. Singh SP, Chawla YK. 1st ed. Kalinga Gastroenterology foundation. (2004): 17-24.
  4. Batham A., et al. “Systemic review and meta-analysis of prevalence of hepatitis B in India”. Indian Pediatrics 44 (2007): 663-674.
  5. Thaygrajan SP., et al. “Epidemiology of hepatitis B in India- a comprehensive analysis. In: Hepatitis B and C- carrier to cancer”. Ed. Sarin SK, Okuda K. 1st ed. Harcourt India Pvt. Ltd, (2002): 25-39.
  6. Leung N. “Hepatitis C virus infection in Asia-Pacific region”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK and Okuda K. 1st ed. Harcourt India Pvt. Ltd, (2002): 171-185.
  7. De Silva HJ and Fonseka MMD. “Epidemiology of hepatitis C in SAARC countries”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK, Okuda K. 1st ed. Harcourt India Pvt. Ltd, (2002): 187-200.
  8. Arankale VA. “Epidemiology of HCV infection in India: a comprehensive analysis”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK, Okuda K. 1st ed.Harcourt India Pvt. Ltd, (2002): 201-218.
  9. Williams R. “Global challenges in liver disease”. Hepatology 44 (2006): 521-526.
  10. Perz JF., et al. “The contribution of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide”. Journal of Hepatology45 (2006): 529-538.
  11. Khan M and Ahmad N. “Epidemiology of hepatitis B in SAARC countries”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK, Okuda K. 1st ed.Harcourt India Pvt. Ltd, (2002): 19-23.
  12. Park YM. “Hepatocellular carcinoma in Asia”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK, Okuda K. 1st ed.Harcourt India Pvt. Ltd, (2002): 267-278.
  13. Mohandas KM andDhir V. “Epidemiology of hepatocellular carcinoma in India”. In: Hepatitis B and C- carrier to cancer. Ed. Sarin SK, Okuda K. 1st ed. Harcourt India Pvt. Ltd, (2002): 279-288.
  14. Tandon BN., et al. “Epidemiology of hepatitis B virus infection in India”. Gut 38 (1996): S56-S59.
  15. Sathiyasekaran M andSankaranarayanan VS. “Hepatitis B virus infection in children in India”. In: Hepatitis B Annual-2004, Ed. Singh SP, Chawla YK. Kalinga Gastroenterology foundation. First edition (2004): 72-91.
  16. Mohandas KM. “Hepatitis B associated hepatocellular carcinoma: diagnosis and epidemiology and treatment”. In: Hepatitis B Annual-2004, Ed. Singh SP, Chawla YK. Kalinga Gastroenterology foundation. First edition (2004): 140-152.
  17. Chowdhury A., et al. “Hepatitis C virus infection in general population: a community-based study in West Bengal, India”. Hepatology 37 (2003): 802-809.
  18. Mukhopadya A. “Hepatitis C in India”. Journal of Bioscience333 (2008): 465-473.
  19. Khaja MN., et al. “Hepatitis C virus: the Indian scenario”. Current Science 83 (2002): 219-224.
  20. Kumar A., et al. “Prevalence and risk factors for hepatitis C virus among pregnant women”. Indian Journal of Medical Research126 (2007): 211-215.
  21. Bagga PK and Singh SP. “Seroprevalence of hepatitis C antibodies in healthy blood donors- a prospective study”. Indian Journal of Pathology and Microbiology 50 (2007): 429-432.
  22. Chongsrisawat V., et al. “Prophylaxis of viral hepatitis: a global perspective”. In: Hepatitis B Annual-2004, Ed. Singh SP, Chawla YK. 1st ed. Kalinga Gastroenterology foundation, (2004): 25-59.
  23. Agrawal R. “Universal neonatal hepatitis B virus vaccination in India: why?” In: Hepatitis B Annual-2004, Ed. Singh SP, Chawla YK. 1st ed.Kalinga Gastroenterology foundation, (2004): 60-71.
  24. Annual report 2009-2010 by National AIDS Control Organization, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India.
  25. Pandey A., et al. “Improved estimates of India’s HIV burden in 2006”. Indian Journal of Medical Research129 (2009): 50-58.
  26. The Gazette of India: Ministry of Environment and Forest, notification, New Delhi, India.
  27. 2001 Census data- Census of India.
  28. Annual report 2004-05 of planning commission, Government of India (2017).
  29. Statistics/India/UNICEF.
  30. District Level HouseHold Survey by International Institute of Population Science, Mumbai, India (2008).
×

Citation

Citation: Sulabhsinh Solanki., et al. “Low Prevalence of Hepatitis B and Hepatitis C Infection in Gujarat and Maharashtra States of Western India". Acta Scientific Microbiology 3.8 (2020): 90-97.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US





+91 9182824667

     info@acta-scientific.com

Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.